Adalimumab Drug
An Adalimumab Drug is a Disease-Modifying Antirheumatic Drug that is a monoclonal antibody that works as a TNF inhibitor.
- AKA: Humira.
- Context:
- It can be owned by AbbVie.
- …
- Example(s):
- …
- Counter-Example(s):
- Abatacept (a T-cell costimulatory signal inhibitor),
- Anakinra (a IL-1 receptor antagonist),
- Baricitinib (a JAK1 and JAK2 inhibitor),
- Certolizumab Pegol (a TNF inhibitor),
- Ciclosporin (Cyclosporin A) (a calcineurin inhibitor).
- See: Pharmaceutical Product, TNF Alpha, Subcutaneous Injection, TNF Inhibitor, Per os, Disease-Modifying Antirheumatic Drug, Monoclonal Antibody, Tumor Necrosis Factor, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Crohn's Disease.
References
2021
- (Wikipedia, 2021) ⇒ https://en.wikipedia.org/wiki/adalimumab Retrieved:2021-10-25.
- Adalimumab, is a disease-modifying antirheumatic drug and monoclonal antibody that works by inactivating tumor necrosis factor-alpha (TNFα).It is sold under the brand name Humira, among others. It is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, psoriasis, hidradenitis suppurativa, uveitis, and juvenile idiopathic arthritis. Use is generally only recommended in people who have not responded to other treatments. It is administered by injection under the skin.
Common side effects include upper respiratory tract infections, pain at the site of injection, rash, and headache. Other side effects may include serious infections, cancer, anaphylaxis, reactivation of hepatitis B, multiple sclerosis, heart failure, liver failure, and aplastic anemia. Use during pregnancy is not recommended, but some sources show use during breastfeeding may be safe.
Adalimumab was approved for medical use in the United States in 2002. It is on the World Health Organization's List of Essential Medicines. It is available as a biosimilar medication. In 2018, it was the 178th most commonly prescribed medication in the United States, with more than 3million prescriptions.
- Adalimumab, is a disease-modifying antirheumatic drug and monoclonal antibody that works by inactivating tumor necrosis factor-alpha (TNFα).It is sold under the brand name Humira, among others. It is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, psoriasis, hidradenitis suppurativa, uveitis, and juvenile idiopathic arthritis. Use is generally only recommended in people who have not responded to other treatments. It is administered by injection under the skin.